Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine and postoperative sleep in tumor surgery patients
ChiCTR2200055180Phase 4Recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Postoperative sleep disturbance (PSD) (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoints: postoperative sleep quality and serum cytokines. Started Dec 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on ChiCTR2200055180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055180.